Flagship-backed microbiome biotech Evelo to shut down
Bio Pharma Dive
NOVEMBER 22, 2023
The company said it had not found “a viable alternative” to closing down in the months since it hit a clinical setback and laid off staff.
Wed.Nov 22, 2023
288 
Eli Lilly supports Alto Neuroscience in $45m Series C round
Pharmaceutical Technology
NOVEMBER 22, 2023
The funding will go towards the development of the company's four CNS candidates, with Phase II study data readouts expected by early 2025.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Freeline, after cuts, agrees to take-private deal with Syncona
Bio Pharma Dive
NOVEMBER 22, 2023
The planned acquisition adds to a string of bargain buyouts and reverse mergers in the gene therapy field.
Signal: Moderna mRNA patent revoked by EPO after Pfizer suit
Pharmaceutical Technology
NOVEMBER 22, 2023
Pfizer and BioNTech countersued Moderna following an initial August 2022 suit alleging that its patents were overly broad.
To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic
Fierce Pharma
NOVEMBER 22, 2023
Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victoza to make more Ozempic.
Genentech and NVIDIA enter generative AI-powered drug discovery deal
Pharmaceutical Technology
NOVEMBER 22, 2023
Genentech has entered a research partnership with NVIDIA to expedite the discovery and development of new drugs.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
US Senate Committee calls pharma giants for another hearing on drug pricing
Pharmaceutical Technology
NOVEMBER 22, 2023
A US senate committee scheduled a hearing on prescription drug pricing with major pharmaceutical companies.
PREDICTOM trial backed by €21m for early Alzheimer’s detection
Pharma Times
NOVEMBER 22, 2023
The trial will use an AI screening platform to identify those most at risk of dementia - News - PharmaTimes
IGC Pharma signs agreement to adopt AI solutions into drug discovery
Pharmaceutical Technology
NOVEMBER 22, 2023
IGC Pharma has entered into an agreement with the University of Los Andes, Colombia, to adopt generative AI solutions for drug development.
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
NOVEMBER 22, 2023
Looking to protect its lucrative immunology drug Rinvoq, AbbVie is suing a clutch of generic drug makers that are attempting to market copycat versions of the blockbuster. | In a lawsuit filed in Delaware federal court Monday, AbbVie accused Sandoz, Hetero Labs, Aurobindo Pharma, Intas Pharmaceuticals and Sun Pharmaceutical of trying to sidestep dozens of patents protecting Rinvoq through the next decade.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Sandoz unveils biosimilar Hyrimoz HCF in Europe
Pharmaceutical Technology
NOVEMBER 22, 2023
Sandoz launches a Hyrimoz citrate-free high-concentration formulation (HCF:100mg/mL), a biosimilar of reference medicine Humira, in Europe.
Thousands of men to participate in UK trial for prostate cancer
Pharma Times
NOVEMBER 22, 2023
Prostate cancer is responsible for 12,000 deaths every year in the UK - News - PharmaTimes
Myricx Bio signs licence deal for WuXi Biologics’s antibody
Pharmaceutical Technology
NOVEMBER 22, 2023
Myricx Bio has signed a licence agreement for contract research, development and manufacturing organisation WuXi Biologics’ antibody.
Promising drug targets to be identified by game-changting technology at MIPS Australia
Outsourcing Pharma
NOVEMBER 22, 2023
An exciting new instrument that will help identify promising drug targets for academia and the pharma industry has been unveiled in Australia by The Monash Institute of Pharmaceutical Sciences (MIPS).
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Why COP28 is “the most important COP” since the Paris Agreement
Pharmaceutical Technology
NOVEMBER 22, 2023
Energy Monitor takes you through what to expect at the UN climate conference taking place in December in Dubai, COP28.
Talking techbio with NVIDIA: Accelerated computing, NLP, and GenAI in drug discovery
pharmaphorum
NOVEMBER 22, 2023
Talking techbio with NVIDIA: Accelerated computing, NLP, and GenAI in drug discovery Mike.
FDA issues Cipla warning letter after thousands of complaints
Pharmaceutical Technology
NOVEMBER 22, 2023
The warning letter issued to Cipla will further delay the launch timelines of the company’s Advair generic in the US.
Novartis drops subpoena request in trade-secret spat with Takeda
Fierce Pharma
NOVEMBER 22, 2023
Novartis has withdrawn its request to access Takeda’s documents as part of an investigation over potential trade secrets theft. | Novartis has withdrawn its request to access Takeda’s documents as part of an investigation over potential trade-secrets theft.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Merz strengthens its global footprint with botulinum approval in Australian market
Pharmaceutical Technology
NOVEMBER 22, 2023
Merz’s drug Xeomin is already approved by the FDA and EMA to treat chronic sialorrhea or excessive drooling.
Investigating Industry Involvement in Modern Clinical Trials
Pharmaceutical Commerce
NOVEMBER 22, 2023
Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.
CellCentric's new ways to treat specific blood cancers published in Cancer Cell journal
BioPharma Reporter
NOVEMBER 22, 2023
A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.
AMR could kill 10 million in 2050, but there’s no profit in stopping it
pharmaphorum
NOVEMBER 22, 2023
AMR could kill 10 million in 2050, but there’s no profit in stopping it Mike.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Promising drug targets to be identified by game-changing technology at MIPS Australia
Outsourcing Pharma
NOVEMBER 22, 2023
An exciting new instrument that will help identify promising drug targets for academia and the pharma industry has been unveiled in Australia by The Monash Institute of Pharmaceutical Sciences (MIPS).
Blow to Moderna as EU nixes mRNA vaccine patent
pharmaphorum
NOVEMBER 22, 2023
Blow to Moderna as EU nixes mRNA vaccine patent Phil.
New patent for Eli Lilly drug OLUMIANT
Drug Patent Watch
NOVEMBER 22, 2023
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are… The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions.
Boehringer buys cancer immunotherapy firm T3 for $507m
pharmaphorum
NOVEMBER 22, 2023
Boehringer buys cancer immunotherapy firm T3 for $507m Phil.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
New patent for Arcutis drug ZORYVE
Drug Patent Watch
NOVEMBER 22, 2023
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in one NDA. It is available from one supplier. There are four patents protecting… The post New patent for Arcutis drug ZORYVE appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacy First: Why technology is necessary for safeguarding pharmacies
pharmaphorum
NOVEMBER 22, 2023
Pharmacy First: Why technology is necessary for safeguarding pharmacies Mike.
New patent for Azurity drug NYMALIZE
Drug Patent Watch
NOVEMBER 22, 2023
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are eight patents protecting… The post New patent for Azurity drug NYMALIZE appeared first on DrugPatentWatch - Make Better Decisions.
Breast cancer researchers to be recognised with SABCS award
Drug Discovery World
NOVEMBER 22, 2023
The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an SABCS cosponsor, will award two researchers for their significant contributions to breast cancer research at SABCS 2023, 5-9 December, at the Henry B González Convention Center in San Antonio, Texas. 2023 AACR Distinguished Lectureship in Breast Cancer Research Dr Kornelia Polyak is the recipient of the 2023 AACR Distinguished Lectureship in Breast Cancer Research.
Accelerating Clinical Supply Through Integrated Drug Development
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content